Thousands of consumers nationwide who purchased the antidepressant drug Remeron or its generic equivalent, mirtazapine, may get cash back based on their out-of-pocket expenses.
The cash recovery is a result of a $36 million nationwide settlement with drug maker Organon USA Inc. and its parent company Akzo Nobel N.V. for allegedly improperly monopolizing the U.S. market […]